Oncidium foundation

About Oncidium foundation

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• PR Newswire · 2026-10-19
  Oncidium Foundation announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.
• Nuclear Medicine Today · 2026-05-12
  Oncidium Foundation expands cyclotron capacity to meet Lu-177 demand
  The work builds on more than a decade of radiochemistry collaboration.
• STAT News · 2026-04-05
  Oncidium Foundation signs supply agreement to support late-stage trials
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Imaging Wire · 2026-11-06
  Oncidium Foundation appoints new Chief Medical Officer ahead of pivotal trial
  Coverage notes the company's growing footprint in the radioligand therapy space.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.